Literature DB >> 1276539

Emetine myopathy in the rat.

W G Bradley, J D Fewings, J B Harris, M A Johnson.   

Abstract

1 (-)Emetine (0.25-2.0 mg/kg i.p.) was administered to rats for up to 220 days. 2 At doses of 1.0 mg/kg or less, the animals continued to gain weight but more slowly than the untreated control animals. The physiological changes in the muscles from these animals were minimal; there was a small reduction in both the resting membrane potential and in the maximum rate of rise of the action potential. There was no atrophy or loss of muscle fibres although in the occasional muscle, hyaline fibres, necrotic fibres and split fibres were observed. There was a focal loss of myofibrillar adenosine triphosphatase (ATPase) and nicotinamide adenine dinucleotide tetrazolium reductase (NADH-TR) in Type II and Type III fibres, but no such loss in Type I fibres. 3 The animals receiving 2.0 mg/kg of (-)emetine gained weight slowly for up to 20 days but then rapidly lost weight and by 30 days they were weak and emaciated. The muscles from these animals were severly atrophied and the total muscle wet weight was reduced by almost 20%. 4 The strength of the muscles from these animals was measured in vitro using direct stimulation. They were weaker than normal both in absolute terms and when expressed in terms of tension developed/unit wet weight. 5 There was no evidence of either functional or structural denervation but surgically denervated muscles from animals in this group were indistinguishable from denervated muscles from normal rats. 6 Severe structural damage was obvious in the fibres of both extensor digitorum longus and soleus. Necrotic, hyaline and splitting fibres were common and the focal loss of myofibrillar ATPase and NADH-TR activity was extensive and occurred in Type I fibres as well as in Type II and Type II fibres. 7 It is concluded that the muscular weakness induced by (-)-emetine is due to a direct effect on the muscle fibres and that this occurs at a subcellular level. There is no evidence that functional or structural denervation plays any role in the aetiology of emetine myopathy in the rat.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1276539      PMCID: PMC1667020          DOI: 10.1111/j.1476-5381.1976.tb07653.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

1.  A study of supersensitivity in denervated mammalian skeletal muscle.

Authors:  J AXELSSON; S THESLEFF
Journal:  J Physiol       Date:  1959-06-23       Impact factor: 5.182

2.  Histochemical comparison of naphthol AS-phosphates for the demonstration of phosphatases.

Authors:  M S BURSTONE
Journal:  J Natl Cancer Inst       Date:  1958-03       Impact factor: 13.506

3.  An investigation of spontaneous activity at the neuromuscular junction of the rat.

Authors:  A W LILEY
Journal:  J Physiol       Date:  1956-06-28       Impact factor: 5.182

4.  Structural basis for inhibition of protein synthesis by emetine and cycloheximide based on an analogy between ipecac alkaloids and glutarimide antibiotics.

Authors:  A P Grollman
Journal:  Proc Natl Acad Sci U S A       Date:  1966-12       Impact factor: 11.205

5.  Effects of blockers of protein synthesis upon fibrillation due to denervation.

Authors:  F Llados; P Zapata
Journal:  Acta Physiol Lat Am       Date:  1974

6.  The correlation of metabolic and ultrastructural changes in emetine myocardial toxicity.

Authors:  M L Murphy; R T Bulloch; M B Pearce
Journal:  Am Heart J       Date:  1974-01       Impact factor: 4.749

7.  The resting membrane potential of fibres of fast and slow twitch muscles in normal and dystrophic mice.

Authors:  J B Harris
Journal:  J Neurol Sci       Date:  1971-01       Impact factor: 3.181

8.  Effect of (minus)-emetine on liver microsomal protein synthesis in partially hepatectomized rats.

Authors:  R K Johnson; J D Donahue; W R Jondorf
Journal:  Xenobiotica       Date:  1971-03       Impact factor: 1.908

9.  Amoebic and bacillary dysentery and the enteric fevers.

Authors:  P E Manson-Bahr; W E Ormerod
Journal:  Practitioner       Date:  1971-08

10.  Experimental hepatic amoebiasis and its application to chemotherapeutic studies.

Authors:  G A WILLIAMS
Journal:  Br J Pharmacol Chemother       Date:  1959-12
View more
  7 in total

1.  Myopathy from surreptitious ipecac ingestion.

Authors:  N L Rosenberg; S P Ringel
Journal:  West J Med       Date:  1986-09

2.  Praziquantel failure in the treatment of Fasciola hepatica.

Authors:  D M Patrick; J Isaac-Renton
Journal:  Can J Infect Dis       Date:  1992-01

Review 3.  Adverse effects of drugs on muscle.

Authors:  F L Mastaglia
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

4.  Experimental emetine myopathy: enzyme histochemical, electron microscopic, and immunomorphological studies.

Authors:  N J Hopf; H H Goebel
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

5.  Ultrastructural pathology in emetine-induced myopathy.

Authors:  L Halbig; L Gutmann; H H Goebel; J F Brick; S Schochet
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

6.  Reversible emetine-induced myopathy with ECG abnormalities: a toxic myopathy.

Authors:  T Kuntzer; J Bogousslavsky; J P Deruaz; R Janzer; F Regli
Journal:  J Neurol       Date:  1989-05       Impact factor: 4.849

Review 7.  Proliferative and non-proliferative lesions of the rat and mouse soft tissue, skeletal muscle and mesothelium.

Authors:  Peter Greaves; Luc Chouinard; Heinrich Ernst; Lars Mecklenburg; Ingrid M Pruimboom-Brees; Matthias Rinke; Susanne Rittinghausen; Stéphane Thibault; Jasmin Von Erichsen; Toshinori Yoshida
Journal:  J Toxicol Pathol       Date:  2013       Impact factor: 1.628

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.